Drawing for DV DIAGNO VITAE

USPTO serial 79206277

DV DIAGNO VITAE

Reviewed by CopyMark Law Group

Reg. 5572536Status 709
Filing date
Status date
Registration date
Oct 2, 2018
Examiner
DIBLE, JONATHON I
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DV DIAGNO VITAE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Valerie Brennan

Valerie Brennan Hogan Lovells US LLP7930 Jones Branch Drive, 9th FloorBox Intellectual PropertyMcLean, VA 22102

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical products, namely, diagnostic biomarker reagents for medical purposes, genetic identity tests comprised of reagents for medical purposes, pharmaceutical products for ophthalmological use; pharmaceutical products, namely, contact lens care products, namely, cleaning solutions for contact lenses, preservative solutions for contact lenses, sterilizing solutions for contact lenses, rinsing solutions for contact lenses, neutralizing solutions for contact lenses and wetting solutions for contact lenses; medical preparations, namely, diagnostic preparations for medical purposes, chemical reagents for medical purposes; veterinary preparations, namely, diagnostic preparations for veterinary purposes, chemical reagents for veterinary purposes; dietetic food and substances, namely, dietetic foods and beverages adapted for medical purposes, dietetic foods and beverages adapted for veterinary purposes, dietary and nutritional supplementsSECTION 71 - CANCELLED—
044medical and health services, namely, DNA screening and genetic testing for medical purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 30, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 10, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 10, 2026INPCINVALIDATION PROCESSED—
Dec 18, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 18, 2025C71TCANCELLED SECTION 71—
Oct 2, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 23, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 1, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 15, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 15, 2019FIMPFINAL DISPOSITION PROCESSED—
Jan 2, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 2, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 17, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 17, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 13, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jun 27, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 27, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 27, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 8, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 7, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 7, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jun 7, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 7, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 7, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
May 25, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 25, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 24, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 9, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 11, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 11, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Dec 11, 2017CNSLSUSPENSION LETTER WRITTEN—
Nov 3, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 3, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 30, 2017ALIEASSIGNED TO LIE—
Oct 19, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 1, 2017RFNTREFUSAL PROCESSED BY IB—
Jun 9, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 9, 2017RFRRREFUSAL PROCESSED BY MPU—
May 27, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 26, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2017DOCKASSIGNED TO EXAMINER—
May 9, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
May 4, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 27, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance